BROMOTEMIA 2.5MG 15 VAG. SUPP

ABOUT BROMOCRIPTINE DOPAMINE AGONIST ERGOT- ALKALOID ANTI PARKINSONSM HYPOPROLACTINEMIC. MECHANISM OF ACTION OF BROMOCRIPTINE BROMOCRIPTINE IS A DOPAMINERGIC AGONIST. IT ACTS AS A POTENT AGONIST ON D2 RECEPTOR AND PARTIAL AGONIST OR ANTAGONIST ON D1 RECEPTOR. BROMOCRIPTINE PRODUCES A DECREASE IN DOPAMINE TURNOVER WITH INCREASE IN DOPAMINE CONTENT OF THE BRAIN AND DECREASES THE METABOLISM OF DOPAMINE. THE INCREASE IN DOPAMINE CONCENTRATION PRODUCES EFFECT IN PARKINSON`S DISEASE. SINCE DOPAMINE IS A NEUROTRANSMITTER IN THE BRAIN IT CAN PRODUCES VARIOUS MOTOR BEHAVIOURAL AND ENDOCRINE EFFECTS. HORMONAL ACTION: BROMOCRIPTINE INHIBITS SYNTHESIS AND RELEASE OF PROLACTIN FROM PITUITARY LACTOTROPE CELL BY ACTING AS A D2 AGONIST. INDICATIONS FOR BROMOCRIPTINE 1.PARKINSON`S DISEASE 2.AMENORRHEA AND GALACTORRHEA ASSOCIATED WITH HYPERPROLACTINEMIA 3.ACROMEGALY 4.HEPATIC ENCEPHALOPATHY 5.PREMENSTRUAL SYNDROME 6.CUSHING`S SYNDROME 7.SUPPRESSION OF ESTABLISHED LACTATION.